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Background: Members of the Semaphorin 3 family (Sema3s) influence the development of the central nervous
system, and some are implicated in regulating aspects of visual system development. However, we lack information
about the timing of expression of the Sema3s with respect to different developmental epochs in the mammalian
visual system. In this time-course study in the rat, we document for the first time changes in the expression of RNAs
for the majority of Class 3 Semaphorins (Sema3s) and their receptor components during the development of the
rat retina and superior colliculus (SC).
Results: During retinal development, transcript levels changed for all of the Sema3s examined, as well as Nrp2,
Plxna2, Plxna3, and Plxna4a. In the SC there were also changes in transcript levels for all Sema3s tested, as well as
Nrp1, Nrp2, Plxna1, Plxna2, Plxna3, and Plxna4a. These changes correlate with well-established epochs, and our data
suggest that the Sema3s could influence retinal ganglion cell (RGC) apoptosis, patterning and connectivity in the
maturing retina and SC, and perhaps guidance of RGC and cortical axons in the SC. Functionally we found that
SEMA3A, SEMA3C, SEMA3E, and SEMA3F proteins collapsed purified postnatal day 1 RGC growth cones in vitro.
Significantly this is a developmental stage when RGCs are growing into and within the SC and are exposed to
Sema3 ligands.
Conclusion: These new data describing the overall temporal regulation of Sema3 expression in the rat retina and
SC provide a platform for further work characterising the functional impact of these proteins on the development
and maturation of mammalian visual pathways.
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The mammalian visual system is complex, and the de-
velopmental events that give rise to this highly organised
system are similarly complex and exquisitely ordered.
The timing of the major developmental events of the
mammalian visual system has been well characterised,
and many of the molecular cues controlling these critical
events have been elucidated (for example Ephs/Ephrins,
Slits/Robo, Netrin/DCC, and various neurotrophic factors
[1-7]). However despite our increased knowledge about
these molecular cues, they are not sufficient to explain
completely the complexity and timing of the development* Correspondence: anil@propriocept.com
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unless otherwise stated.of visual pathways in mammals. It is likely then that other
molecules are also involved during the development and
maturation of the mammalian visual system, and in this
context recent attention has turned to the Semaphorins.
Semaphorins (Semas) have been implicated in neural
and vascular aspects of visual system development in
various species including frog [8,9], zebrafish [10-14],
goldfish [15], and chicken [16-21]. In mouse the mem-
brane bound Class 5 and Class 6 Semaphorins are in-
volved in lamination of the retina [22-24], and guidance
of retinal ganglion cell (RGC) axons [25] via contact-
mediated interactions. However many previously discov-
ered molecular cues in the mammalian visual system are
diffusible, and the only vertebrate secreted members of
the Semaphorins are the Class 3 Semaphorins (Sema3s)
[26] which are known to be expressed in the developingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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influence the complexity and timing of the developing
mammalian visual system.
The Sema3s consist of Sema3a through Sema3g
[16,26,28-36] and their main receptors are the Neuropilins
which form multimeric receptor complexes with Plexins
and cell adhesion molecules [37]. Sema3s were initially dis-
covered as axon guidance molecules [30,38], but are now
known to also mediate apoptosis, cell migration, immune
response, organogenesis, tumour suppression and promo-
tion, and vasculature development [39-44]. Sema3s affect at
least some aspects of the development of the visual system
of rodents [45,46], from where much of our knowledge of
molecular and activity-driven influences on mammalian
visual system development has come [6,47].
In summary, while we understand much about the
timing of developmental events in the mammalian visual
system, investigation of a potential role for the Sema3s
in these events would benefit from knowledge about the
timing of expression of Sema3s and their receptors dur-
ing visual system maturation. We sought to address this
gap in our knowledge by building on a previous study
from our laboratory [27], focusing on Sema3s known to
be expressed in RGCs and extending the work to include
a greater number of receptors as well as analysis of a
major central target for those RGCs, the superior collicu-
lus (SC). To that end, we quantified transcript expression
in the rat retina and SC over a range of embryonic (E) and
postnatal (P) developmental time points (E16, E19, birth –
P0, P7, P14, P21 and adult) which were chosen to corres-
pond to previously established developmental epochs such
as the timing of cell birth, migration, naturally occurring
cell death, axonal and dendritic growth, and synaptogene-
sis (Figure 1). We also investigated the hypothesis that
Sema3 ligands in the SC can influence RGC axon guid-
ance using an in vitro growth cone collapse assay on iso-
lated RGCs from a developmental stage when they would
be growing into and within the SC in vivo.
Results
Developmental expression profiles for the Sema3s and
their receptors are presented in Figures 2, 3, 4 and 5,
with those showing statistically significant changes in
expression explored further. Statistical comparisons il-
lustrated in Figures 2, 3, 4 and 5 are summaries of sta-
tistically significant peaks in expression; the entirety of
statistical comparisons can be found in Additional file 1:
Table S1. Plxna3 in situ hybridisations at P1 and P7 are
presented in Figure 6 showing co-expression in βIII-
tubulin positive cells (presumptive RGCs). The effects of
exogenous recombinant Sema3s on RGC growth cone
collapse are presented in Figure 7, and data detailing ex-
pression and detection of those recombinant Sema3s are
presented in Additional file 2: Figure S1.Changes in Class 3 Semaphorins and their receptor
components during rat retinal development
Expression levels in the retina could be separated into three
qualitative groups: relatively high expression of Sema3f and
Plxna2; moderate expression of Nrp1 and Plxna1; and rela-
tively low expression of the rest (Figures 2, and 3). There
were statistically significant changes in the level of expres-
sion of all Sema3 RNAs in the retina, while of the receptors
only Nrp2, Plxna2, Plxna3, and Plxna4a showed statisti-
cally significant changes (Figures 2, and 3; Additional file 1:
Table S1).
Relative to other time points, Sema3a transcript ex-
pression levels were significantly increased at P14 and in
the adult. Similar to Sema3a, Sema3b transcript expres-
sion was relatively stable during retinal development
until P14, at which time there was increased expression
that was maintained into adulthood. Sema3c RNA ex-
pression was also relatively steady through to P0, in-
creasing significantly through to P21, and remaining at
that level into the adult. Sema3e RNA levels appeared to
increase gradually with retinal maturation and were sig-
nificantly higher than E16-P7 levels at P21 and in adult
rats. Sema3f transcription was temporarily greater at P0
and then increased again at P21 and beyond. Nrp2 RNA
expression gradually increased throughout retina matur-
ation, levels at P7 and beyond being significantly greater
than in embryos. Plxna2 and Plxna3 showed nearly
identical patterns of altered transcript expression during
development, both peaking significantly at the time of
birth (P0). Plxna4a RNA levels peaked later at P7, but
also again in the adult.
Many of the significant peaks in transcript expression
occurred after the main developmental epochs. However,
the changes that were quantified in the retina before P21
occurred during periods of RGC apoptosis, and synapse
generation and maturation.
Changes in Class 3 Semaphorins and their receptor
components during development of the rat superior
colliculus
There were four qualitative groups of transcript expression
levels in the SC: Plxna1 having the highest; followed by
Sema3f, Nrp1, and Nrp2; then Sema3b, Sema3c and Plxna3;
and lower amounts for the remainder (Figures 4, and 5).
With the exception of L1cam, all genes of interest changed
expression significantly during SC maturation.
Sema3a RNA levels were highly variable at E16 (149%
coefficient of variance; CV), peaked at E19, and a decline
with increasing postnatal age. The expression profile of
Sema3b differed from other transcripts; there was large
biological variation at many time points, with CVs greater
than 100%, and four apparent peaks in expression, only
one of which reached significance (E19). Sema3c tran-
script expression peaked at E19 and P0, before falling to
Figure 1 Developmental epochs in the rat neural retina and superior colliculus. Cytogenesis in the rat retina occurs from E9 through to
P12, with distinct and overlapping waves of cell birth and differentiation [48–51]. Death of differentiated retinal ganglion cells (RGCs) is predominantly
perinatal; starting at E20, peaking between birth and P3, falling sharply at P5 and continuing on until around P10 [52–57]. Astrocyte apoptosis is observed
from P0, peaking between then and P5, and is associated with vasculature development [51,58]. Bipolar and amacrine cell apoptosis occurs concurrently
with different peaks, from P5 until P13/P14 [54]. Synapse generation in the inner plexiform layer (IPL) starts at P2 with amacrine cells [59,60], and from
P12 in bipolar cells [59], both peaking around the time of eye opening [54,59]. Outer plexiform layer (OPL) synaptogenesis begins at P4 [59–62] and,
while its time-course in the rat is not certain, in the mouse continues until about P12 [63]. Neurogenesis in the rat superior colliculus (SC) occurs from
E12 to E17 [64,65]. Apoptosis in the visual layers of the rat SC (stratum griseum superficiale; SGS) occurs from birth, peaking at between P4 and P7, and
lasting until P13 [66,67]. Circuit maturation in the SGS, as judged by synapse density and composition, is mostly postnatal [68,69] in three stages: P0-P12/
P14 (eye opening), P12-P24 increasing number of synapses, P21-P30/P40 increasing ratio of inhibitory to excitatory terminals [70]. Retinal axons first enter
the SC at E16/E17 [71], and continue to arrive until P5/P6 [52,72]. Cortico-tectal innervation starts at P3, with marked ingrowth between P6 and P12, and
adult-like innervation observable from P18 [73]. Scale: downwards ticks mark 5 days, upwards ticks mark time points in this study; IPL: inner plexiform
layer; OPL: outer plexiform layer; RGC: retinal ganglion cell; SGS: stratum griseum superficiale.
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Sema3s, Sema3e transcript levels increased steadily from
E16 to P14, before a decrease at P21, then again increased
in the adult. Sema3f expression was highest at E16 and
E19, with RNA levels lower at birth and remaining at
those reduced levels during postnatal development. There
was relatively high biological variation in expression levels
of Nrp1, Nrp2 and all PlexinAs at E16 and E19 (CV >
100%) compared to other time-points. Nrp1 RNA expres-
sion peaked at E19 then decreased steadily to P7 at levels
that were maintained into the adult. Nrp2 transcript levels
peaked at E19 before falling steadily to E16 levels at P7
and beyond. Plxna1 RNA expression also peaked at E19, a
pattern that was repeated for the remaining three PlexinARNAs, all of which had significantly decreased RNA ex-
pression by P0 and P7 that remained at low levels into
adulthood.
The patterns of expression of Sema3s in the developing
SC were substantially different from those seen in the retina,
with peak expression occurring around or before birth.
Temporally, these changes in transcript expression occurred
during the period of SC neurogenesis, synapse generation
and maturation, and innervation of the SC by extrinsic affer-
ents including those from the retina and visual cortex.
Expression of Plxna3 in the neonatal retina
Our qPCR data showed that peak Plxna3 RNA expres-
sion in the retina occurred during the period of peak
Figure 2 RNA expression levels of the Class 3 Semaphorins in the rat retina during development. Sema3s: Sema3f is the most predominant
transcript, and Sema3a the least. All transcripts increased expression through development and maintained relatively high levels into adulthood. Sema3a:
Expression rises slightly to a peak at P14, dropping at P21 before rising again at adulthood. Sema3b: Expression is lowest in the embryonic retina, around
half that found from P14 onwards. Sema3c: Transcription is stable up to P0 then rises twofold by P21 and into adulthood. Sema3e: Expression levels rise
steadily after birth, reaching fourfold higher levels at their peak in the adult. Sema3f: There are two periods of increased expression, a doubling at birth
before falling again by P7 and then rising back by P21 and into adulthood. Error bars are SEM; * p < 0.05, ** p < 0.01; n = 4–5.
Sharma et al. BMC Developmental Biology 2014, 14:34 Page 4 of 14
http://www.biomedcentral.com/1471-213X/14/34RGC apoptosis (Figure 3). While rat retinal cells ex-
pressing the Sema3 receptor components Nrp1, Nrp2,
Plxna1 and Plxna2 have previously been identified using
ISH [74] there has been no such characterisation for
Plxna3. We used ISH to examine the cellular location of
Plxna3 transcripts in P1 and P7 rat retinas (Figure 6) and
found that Plxna3 RNA was clearly expressed in the gan-
glion cell layer at both these ages, with transcript expression
overlapping βIII-tubulin (RGCs) immunostaining. This is in
agreement with previously published data in the mouse ret-
ina [22]. Qualitatively, changes in the level of Plxna3 ex-
pression in our ISH data are consistent with the reduction
in expression between P0 and P7 in our qPCR material.
Growth cone collapse assay for purified neonatal RGCS
in vitro
It has been suggested that Sema3s in the SC can assist
in the guidance of ingrowing RGC axons [45], and our
data revealed increased expression of these ligands inthe SC during this period (Figure 4). To further investi-
gate the capability of Sema3s to influence RGC axons as
they grow into and within the SC we used a growth cone
collapse assay to assess the capacity of developmentally
appropriate RGCs to respond to Sema3 proteins. Re-
combinant Sema3 proteins (SEMA3A-GFP, SEMA3C-
FLAG, SEMA3E-FLAG, and SEMA3F-AP) in condi-
tioned media were used to challenge immunopurified
P1/P2 RGCs in vitro. These proteins were detected in
the conditioned media by western blot against their arti-
ficial epitopes (Additional file 2: Figure S1A). Detected
bands for SEMA3A-GFP correspond to the approxi-
mately 130 kDa and 90 kDa bands reported previously
[75]. SEMA3C-FLAG was detected at around 80 kDa as
expected, and also in a presumably processed form at
around 70 kDa. Both SEMA3C-FLAG and SEMA3E-
FLAG were detected in media at approximately 100 kDa,
which might represent glycosylated forms of the proteins.
SEMA3F-AP was detected at 150 kDa, in line with
Figure 3 RNA expression levels of the Class 3 Semaphorin receptors in the rat retina during development. Receptors: Nrp1 transcript
levels are around twofold higher than the peak level of Nrp2. Co-receptors: Plxna2 had the highest peak expression levels, and L1cam the lowest.
Plxna2 and Plxna3 expression levels are very similar, with Plxna2 having around fourfold higher peak levels. Nrp2: RNA levels are lowest in the em-
bryo, rising from P7 onwards and peaking at around fourfold higher in the adult. Plxna2: Expression peaks at birth at fivefold higher than at E16,
drops again by P14 and is maintained at that level into the adult. Plxna3: RNA levels increase fourfold from E16 to their peak at birth before falling
back to embryonic levels by P21. Plxna4a: Expression triples from E16 to P0, doubles again at P7, falls back one third by P21 before increasing
again to peak in the adult. Error bars are SEM;* p < 0.05; n = 4–5.
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epifluorescence and immunocytochemistry and were posi-
tive for recombinant proteins while appropriate controls
were negative (Additional file 2: Figure S1B-G).
Growth cones were visible as F-actin positive exten-
sions from the ends of βIII-tubulin positive neurites.
Typically uncollapsed growth cones displayed the com-
mon ‘hand like’ morphology, and collapsed growth cones
appeared as thin stumps. Growth cones were counted
only at the end of neurites, even when significant growth
cone-like processes were observed along the shaft of a
neurite, as these lateral extensions can occur in response
to the collapse of the leading growth cone [76]. Exam-
ples of collapsed versus uncollapsed growth cones are il-
lustrated in Figure 7. Cultures treated with conditioned
media containing any of the Sema3s had significantly
higher percentages of collapsed growth cones, with theaverage percentage of the two replicates and statistical sig-
nificance level presented in Figure 7A. Our data demon-
strate that neonatal rat RGCs are competent to respond to
SEMA3A, SEMA3C, SEMA3E, and SEMA3F proteins at a
developmental time point during which their axons are en-
tering into and growing within the SC in vivo [52,71,72].
Discussion
We found statistically significant changes in gene ex-
pression of Sema3s and their co-receptors during matur-
ation of the rat retina and SC. These changes differed in
degree and time-course between the retina and SC so
were not due to generalised or non-specific systemic
changes. It is likely that the observed tissue-specific
changes in expression reflect the biological roles of these
molecules and are in some way related to the development
and maturation of each structure [20,21,45]. While our
Figure 4 RNA expression levels of the Class 3 Semaphorins in the rat superior colliculus during development. Sema3s: All Sema3 RNA
expression levels, except for Sema3e, peak at E19 and are lowest by P21 and into the adult. Sema3b, Sema3c and Sema3f are the predominant
transcripts with around 100 times higher levels than Sema3a and Sema3e. Sema3a: There is a high variability in expression at E16, peak expression
at E19, falling twofold by birth and eightfold in the adult. Sema3b: Expression changes markedly throughout development, with high variability levels
at both E19 and P14. Expression rises twenty-eightfold from E16 to E19 before falling back 17 fold by P7 and back to E16 levels at P21. Transcript levels
then rise eightfold from P21 to adult. Sema3c: RNA levels peak at E19 and P0, falling twofold by P14 and maintaining that level into the adult. Sema3e:
Transcript levels double and triple from the embryo to P7 and P14 respectively, dropping back at P21 and increasing again into the adult. Sema3f: RNA
expression levels are highest in the embryo, dropping fivefold after birth and into the adult. Error bars are SEM; * p < 0.05; n = 4–5.
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cell populations, previous work in the retina suggests that
the transcripts studied are heavily expressed in rat RGCs
[27]. Importantly we also showed that neonatal rat RGCs
are competent to respond to Sema3s at a developmental
time point when their axons are encountering the Sema3s
in the SC. We are wary of over-analysing temporal associ-
ation data, but to help place our results in context we
briefly discuss our data below with respect to known de-
velopmental processes (Figure 1).
Class 3 Semaphorins and morphogenesis of the retina
and superior colliculus
Sema5s and Sema6s are known to mediate lamination of
the mouse retina, signalling through Plxna2, Plxna3 and
Plxna4 [22-24]. In addition, Sema3s guide cells as theydifferentiate and migrate within CNS tissues such as the
cortex, cerebellum, and hippocampus [39,77,78], and pre-
sumably they are able diffuse through tissues like other
guidance cues in the mammalian visual system such as
the Ephs and Netrin. Is the expression of Sema3s also in-
volved in morphogenesis of the rat retina and SC? Retinal
neurogenesis occurs from E10/E11 through to the second
postnatal week [48], and while there is expression of all
Sema3s and their receptors and co-receptors during much
of this period, expression levels are for the most part rela-
tively low. Rod photoreceptor generation peaks at P0, as
does transcript expression of Sema3f, Plxna2 and Plxna3
RNAs. However there appears to be very little Sema3f
transcript expression in the outer nuclear layer (ONL) at
this age [27], despite evidence of relatively high expression
of Sema3f RNA in the ONL of adult mice [79].
Figure 5 RNA expression levels of the Class 3 Semaphorin receptors in the rat superior colliculus during development. Receptors: Nrp1
and Nrp2 share similar expression profiles, with peaks around E19 and birth and then falling away into the adult. Co-receptors: All co-receptors
bar L1cam follow the same expression profile, peaking at E19 before falling after birth and into the adult. Plxna1 and Plxna3 are the predominant
transcripts. Nrp1: Peak RNA expression is at E19, falling threefold by P7 and maintained into the adult. Nrp2: Transcript levels double from E16 to
P0, with high variability at E19. Expression falls from P0 to P7 and is maintained at around half peak levels in the adult. Plxna1: RNA levels are
highly variable at E16 and E19 where they peak. From birth expression levels are halved, continue to decline up to P21 where they are sevenfold
lower than at peak, and this level is maintained into the adult. Plxna2: RNA levels are highly variable at E16 and E19 where they peak. Expression
drops threefold by P7 and is maintained into the adult. Plxna3: RNA levels are highly variable at E16 and E19 where they peak. Expression falls to
half peak at P7, one quarter peak at P14 and is sevenfold lower than peak by P21 and in the adult. Plxna4a: RNA levels are highly variable at E16
and E19 where they peak before falling fourfold by P7 and into the adult. Error bars are SEM; * p < 0.05; n = 4–5.
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E12 to E17 [64,65] and the SC has an adult like laminar
structure at P7 [80]. Sema3c and Nrp2 RNA expression
displayed the same upwards then downwards sweep as
neurogenesis in the SC: elevated at E19 and P0, falling
by P7. Similarly, Sema3a, Sema3b, and Sema3f as well as
Nrp1 and all PlexinA co-receptors showed peak expres-
sions at E19 that declined thereafter, coincidental withearly cytoarchitectural patterning of the SC. These data
therefore suggest that the Sema3s might play a role in
patterning the SC, but not the retina.
Class 3 Semaphorins and retinal ganglion cell apoptosis
Sema3s, specifically Sema3a and Sema3f, have been
implicated in apoptosis of neurons including RGCs
[81–86]. During retinal development, RGC apoptosis is
Figure 6 Location of Plxna3 transcript in the neonate rat retina. Double in situ hybridisation (ISH) and immunofluorescence staining in P1
(A-C) and P7 retina (D-F). Expression was restricted mainly to the ganglion cell layer (GCL), with overlap of Plxna3 ISH and βIII-Tubulin positive
putative retinal ganglion cells (C,F). GCL and dark arrows: ganglion cell layer; scale bars: 50 μm.
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three genes that had clear peaks in retinal RNA ex-
pression at P0: Sema3f, Plxna2, and Plxna3. Interest-
ingly, Plxna2 and Plxna3 are co-receptors for Sema3f
and Sema3a [37], and Plxna3 has been shown to be
directly involved in Sema3a mediated cell death [84].
Sema3a, Sema3f, and Plxna2 are expressed in neonatal
rat RGCs [27], and we here show that in the rat Plxna3
RNA is predominantly expressed in the retinal gan-
glion cell layer (presumptive RGCs) at P1 (Figure 7).
Importantly we also showed that P1/P2 rat RGCs were
responsive to both Sema3a and Sema3f (Figure 7). Our
data provide further suggestive evidence that the
Sema3s may influence RGC apoptosis.
Class 3 Semaphorin expression during the period of
synapse generation and maturation in retina and superior
colliculus
Sema3s are also involved in terminal axon branching,
synaptogenesis, pruning of terminal arbors, regulation of
synaptic plasticity, and maturation of dendrites [42,87–
92]. Synaptogenesis in the rat retina starts around P2
and is ongoing at P7 [54,59–62], when transcripts for
Sema3c and Sema3e both become more abundant. Con-
versely, Sema3b and Sema3f RNAs increased after comple-
tion of retinal synaptogenesis (P14) [63]. The maintained
relatively high transcript levels in the adult rat retina of
Sema3b, Sema3c, Sema3e, and Sema3f might indicate a
role in regulating synaptic plasticity in the mature retina. It
has been reported that Plxna2, Plxna3, and Plxna4 areimportant for proper lamination of the inner plexiform
layer (IPL) of the mouse retina, with mRNA expressed in
amacrine cells and protein heavily expressed in the IPL
[22–24]. We see no clear signal supporting this finding in
the rat retina, although this may be a consequence of
analysing global rather than cellular expression. In the
SC, the majority of synaptogenesis is postnatal [68–70],
and Sema3e RNA expression in the SC peaks during the
period when many synapses are being formed (P14) sug-
gesting a role for this molecule in SC synaptogenesis.
Effect of Sema3s on guiding RGC and other axons into
and within the superior colliculus
RGC axons enter the rat SC between E16 and P5/P6
[52,71,72], and previous results suggest that Sema3f may
contribute in helping to guide these axons to their cor-
rect retinotopic targets [45]. Furthermore, the Sema3
co-receptor L1cam is required for correct mapping of
retinal axons in the mouse [93,94]. Previous data reveal
that during development of the mouse SC at least some
of the retino-tectal afferent fibres are positive for Nrp1,
Nrp2, and L1cam [93–95], and P1 mouse RGC axons
express the receptors Nrp2 and Plxna1 [45]. While pre-
vious studies have shown responsiveness of some rodent
RGCs to some Sema3s [45], these were not conducted at
a developmental time point where the RGC axons are
growing into and within their Sema3 expressing targets
[52,71,72]. Here we show for the first time that rat P1/
P2 RGCs are capable of responding to exogenous Sema3
proteins at an age when many of these neurons are
Figure 7 Collapse assay of immunopurified P1/P2 rat retinal ganglion cells exposed to exogenous recombinant Sema3 proteins. P1
retinal ganglion cells (RGCs) were immunopurified and seeded in BD Culture Slides coated with PDL and laminin, grown overnight. The following day
(effectively P2), RGCs were exposed to recombinant Sema3s for 30 minutes before fixation and immunostaining. Growth cones were considered
collapsed if the F-actin did not extend past the end of the βIII-tubulin positive neurite with an arc of less approximately 60°. Only terminal growth
cones were counted, because lateral extensions can occur in response to the collapse of the leading growth cone. Additionally, growth cones were
only scored if their neurites were at least two soma widths long. All cultures treated with conditioned media containing recombinant Sema3 proteins
showed statistically significantly higher numbers of collapsed growth cones when compared to cultures treated with control conditioned media (A).
Also shown here are examples of neurons from each culture condition with growth cones scored as collapsed (hollow arrows) and uncollapsed (solid
arrows). Solid arrows: uncollapsed growth cones; hollow arrows: collapsed growth cones; *** p < 0.001; scale bar: 20 μM.
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within the SC. [52,71,72]. Our data show that almost all
these Sema3s, bar Sema3e, had peak expression levels in
the SC during this period of retinal afferent ingrowth,
but that Sema3c and Sema3f had around tenfold higher
expression compared to Sema3a and Sema3e. This dif-
ference in RNA expression levels might indicate that if
these molecules are having an effect then the more likely
candidates are Sema3c and Sema3f. However, some cau-
tion must be used when extrapolating levels of RNA ex-
pression to physiological significance; L1cam, Plxna3
and Plxna4a all had relatively low expression in the ret-
ina despite their known effects in patterning the retina
[22,23,93,94]. Nevertheless, our data do support thesuggestion that Sema3f may play a role in the formation
of the retinotopic map in the mammalian SC [45].
Sema3s have also previously been shown to influence the
pattern of long-distance cortico-tectal projections [96]. Rat
visual cortical axons reach the SC at about P3, with marked
ingrowth between P6 and P12, and then final maturation
between P12-P18 [73]. Our data show elevated Sema3e ex-
pression during this period of ingrowth and maturation of
cortical fibers in the SC, suggesting that Sema3e might in-
fluence the development of corticotectal projections.
Conclusions
In conclusion, the analysis of the Sema3s and their co-
receptors in the developing rat visual system revealed a
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the retina, mRNA expression levels changed for all
Sema3s examined and there were age-specific changes in
Nrp2, Plxna2, Plxna3, and Plxna4a mRNA expression.
In the SC there were also maturational changes in tran-
script levels for all Sema3s, Neuropilins, and PlexinAs,
although the time-course of these changes differed
markedly from those seen in the retina. These develop-
mental changes were associated with periods of RGC
apoptosis; neurogenesis in the SC; synapse generation,
maturation, and plasticity in the retina and SC; and in-
nervation by retino- and cortico-tectal axons in the SC.
Importantly, and consistent with a broad role for the
Sema3 family in the maturing visual system, purified P1/
P2 RGCs were sensitive to Sema3a, Sema3c, Sema3e,
and Sema3f mediated growth cone collapse in vitro.
These new data, providing a framework for future stud-
ies aimed at elucidating such roles of the Sema3s. These
new data describing the overall temporal regulation of
Sema3 expression in the rat retina and SC highlight mat-
urational events that might be influenced by Sema3s,
providing a platform for further work characterising the
functional impact of these proteins on mammalian visual
system development.
Methods
Experiments conformed to the Australian National Health
and Medical Research Council (NHMRC) guidelines and
were approved by the Animal Ethics Committee of The
University of Western Australia. Animals were sourced
from the Animal Resources Centre (Western Australia).
All statistical tests were performed using SPSS v19 (IBM,
USA). E0 was the day vaginal plug detected, P0 was date
of birth.
Tissue collection
Tissue collection for qPCR
Embryonic Wistar rats aged E16 or E19 were dissected
after caesarean section from mothers under halothane an-
aesthesia (5% (v/v) halothane (Rhone Merieux, Australia)
in 80:20 N2O:O2) and immediately placed in ice-cold F-10
media (Gibco, Australia). Dams were sacrificed by intra-
peritoneal (IP) overdose (50 mg/100 g body weight) of
pentobarbitone sodium (Lethabarb; Virbac, Australia).
Postnatal and adult (8 to 10 week old) rats were anaesthe-
tised by overdose of Lethabarb (IP, 32.5 mg/100 g body
weight). Eyes and SCs were quickly dissected out and
placed into fresh ice-cold F-10 media. Retinas were dis-
sected free of the surrounding tunica and vitreous, left
and right retinas pooled and placed immediately into
RNAlater (Ambion, USA). Similarly, SCs were dissected
free of surrounding meninges and placed in RNAlater. All
tissues stored in RNAlater were cooled to 4°C within one
hour for overnight storage, before transfer into −20°C forlonger term storage. Four to five animals were used per
group.Tissue collection for in situ hybridisation
P1 and P7 Wistar rats were anaesthetised by overdose
injection of Lethabarb before transcardial perfusion with
0.05% (w/v) heparin (David Bull Laboratories, Australia)
in phosphate buffered saline (PBS), followed by 4% para-
formaldehyde (w/v; Sigma-Aldrich, Australia) in 0.1 M
Sorenson’s Buffer (4% PFA; pH 7.4). Eyes and whole
brains were dissected out and postfixed in 4% PFA for
30 minutes before cryoprotection in diethylpyrocarbo-
nate (DEPC; Sigma-Aldrich, Australia) treated PBS con-
taining 30% sucrose (w/v; Sigma-Aldrich, Australia)
overnight at 4°C. PBS/sucrose solution was gradually
replaced with Jung tissue freezing medium (Leica
Microsystems, Australia) over several days. After infusion
tissues were snap frozen in isopropanol (2-propanol;
Sigma-Aldrich, Australia). 20 μM sections were cut on a
cryostat, placed on SuperFrost Plus slides (Menzel-Gläser,
Germany), and stored at −80°C until processing by in situ
hybridisation (ISH).qPCR
Methodology for qPCR was as previously detailed [97],
and briefly described here. Total RNA was extracted
with Tri Reagent (Molecular Research Center, USA) and
treated with recombinant DNase I (rDNase I; DNA-free;
Ambion, USA). First strand cDNA was synthesised using
Omniscript (Qiagen, Australia) and random hexamers
(Promega, Australia). Previously validated primer pairs
[97] were used to quantify RNA transcript expressions
of Sema3a, Sema3b, Sema3c, Sema3e, Sema3f, Plxna1,
Plxna2, Plxna3, Plxna4a, Nrp1, Nrp2, L1cam, and in-
ternal reference genes Ppia, Rnr1, and Rpl19. qPCR runs
were performed on either a Rotor-Gene 3000 or 6000
(Qiagen, USA), using Bio-Rad iQ SYBR 2x Mastermix
(Bio-Rad, Australia) in 10 μL reactions containing 500
nM of each primer, and Cq values obtained from using
the inbuilt second derivative maximum (SDM) equation.
qPCR efficiencies are averages of efficiencies calculated
from individual reactions using LinRegPCR [98,99]. Ini-
tial fluorescence levels (N0) were calculated from Cq and
mean efficiency values [100], and then normalised to the
geometric mean of appropriate internal reference genes
[101]. BestKeeper analysis found all internal reference
genes were appropriate internal controls, as judged by
the standard deviation in Cq values. However, Rpl19 was
not used as an internal control because its RNA expres-
sion changed significantly between developmental groups
(Kruskal-Wallis ANOVA, p < 0.05 and p < 0.01 in the ret-
ina and SC respectively), and was relatively poorly corre-
lated to the BestKeeper index SC (Spearman’s R = 0.444).
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mean of Rnr1 and Ppia expression [101].
Normalised data were analysed for changes between
developmental groups by Kruskal-Wallis ANOVA (ana-
lysis of variance). When Kruskal Wallis ANOVA re-
sulted in p < 0.05 pairwise tests of statistical significance
between time points were performed by Mann–Whitney
U tests.In situ hybridisation
Plasmid for Plxna3 riboprobe was kindly provided by
Professor Joost Verhaagen (Netherlands Institute for
Neuroscience, Amsterdam). Sense and anti-sense probes
were produced by restriction endonuclease (RE; New
England Biolabs, USA) digest followed by in vitro RNA
transcription (IVT) with digoxigenin labelled RNA (Roche,
Australia) and RNA polymerase (Roche, Australia). RE
used were: sense, Kpn I; anti-sense, Spe I. Riboprobes were
hydrolysed for one hour at 60°C, precipitated with LiCl
and 100% ethanol, resuspended in DEPC treated double
deionised water (DDW), and stored at −80°C before use.
P1 and P7 retinal sections were processed for ISH with
the above riboprobe using methodology previously de-
scribed [27], with α-dig-AP fragments (Roche, Australia)
and NBT/BCIP (Roche, Australia). Sections were differen-
tiated in 70% ethanol if necessary, and stored in PBS before
proceeding to immunohistochemistry (IHC). Sense ribo-
probes produced limited, diffuse staining, and all experi-
mental runs showed positive anti-sense riboprobe staining
in control tissue (adult rat cerebellum; data not shown).Immunohistochemistry
After ISH processing, sections were processed for im-
munofluorescence using standard methods. Antibody
diluent was 0.1% (w/v) Triton-X100, 10% (v/v) normal
goat serum (NGS; Chemicon, USA), in PBS. Primary
antibody (α-βIII-tubulin (TUJ1); mouse monoclonal,
1:2,000 dilution; Covance, USA) incubation was 4°C over-
night in a humidified chamber, followed by secondary
antibody (α-mouse FITC, goat raised; 1:400 dilution; ICN
Cappel, USA) incubation for 2 hours in a dark humidified
chamber at room temperature. Slides were coverslipped
using fluorescent mounting media (DAKO, Australia).
Cell cultures were stained for βIII-tubulin and F-actin.
βIII-tubulin was labelled by IHC according to standard
practice, using the same antibody diluent, incubation
times, and antibodies as described above. Following im-
munostaining for βIII-tubulin, cultures were incubated
with phalloidin-FITC (Sigma-Aldrich, Australia) diluted
1:1,000 in PBS for 2 hours at room temperature to stain
F-actin, then were washed 3 times with PBS, before being
coverslipped using DAKO fluorescent mounting media.Recombinant Class 3 Semaphorin conditioned media
Expression plasmids (Sema3a-GFP, Sema3c-FLAG, Sema3e-
FLAG, Sema3f-AP) were also a gift from Professor Joost
Verhaagen. The Sema3a-GFP and Sema3f-AP plasmids
have previously been characterised [75,102], containing
rat and mouse cDNA respectively. Sema3c-FLAG con-
tains mouse Sema3c cDNA, and Sema3e-FLAG con-
tains human Sema3e cDNA. Plasmid constructs were
verified by sequencing.
HEK-293 T cultures were grown in DMEM: FBS
(Dulbecco’s Modified Eagle Medium:fetal bovine serum;
Gibco, Australia) 9:1 fortified with gentamycin (50 μg/mL;
Invitrogen, Australia), and then grown without the pres-
ence of antibiotics overnight. Cells were transfected with
plasmids using Lipofectamine 2000 (Invitrogen, Australia),
using Opti-MEM (Invitrogen, Australia) as per manufac-
turer’s instructions. Media was changed to original growth
media with antibiotics 6 hours after transfection, and con-
ditioned media collected 30 hours later. Control condi-
tioned medium was obtained by the same methods, using
sham (no plasmid) transfected cultures.
Immunoprecipitation and detection of recombinant proteins
SEMA3A-GFP was purified from conditioned media using
magnetic GFP-Trap beads (Chromotek, Germany). FLAG
tagged proteins (SEMA3C-FLAG and SEMA3E-FLAG),
and Myc tagged proteins (SEMA3F-AP) were immuno-
precipitated from conditioned media using Dynabeads
Protein A/G (Invitrogen, Australia) and 5 μg α-FLAG
antibody (Sigma-Aldrich, Australia), or 5 μg α-Myc anti-
body (CellSignaling, USA). Proteins were eluted in 2X
Laemmili Buffer (250 mM Tris, 10% (v/v) glycerol, 4%
(w/v) SDS, 2% (v/v) β-mercaptoethanol, 0.005% (w/v)
bromophenol blue, in DDW pH 6.8), separated by SDS-
PAGE (Mini-PROTEAN TGX Stain-Free Precast Gels;
Bio-Rad, Australia) and transferred to nitrocellulose mem-
brane (Trans-Blot Turbo Mini Nitrocellulose Transfer
Pack; Bio-Rad, Australia). Recombinant proteins were de-
tected by western blot using 5% (w/v) skim milk pow-
der in Tris buffered saline containing Tween (TBS-T;
100 mM Tris, 154 mM NaCl, 0.1% (v/v) Tween 20, in DDW
pH 7.5) blocking buffer, α-GFP antibody (mouse monoclonal
clones 7.1 and 13.1, 0.4 μg/mL; Roche, Australia), α-FLAG
antibody (mouse monoclonal, 10 μg/mL; Sigma-Aldrich,
Australia), α-Myc antibody (mouse monoclonal, 1:1,000
dilution; Cell Signaling, USA), and α-mouse-HRP sec-
ondary antibody (1:10,000 dilution; Peirce Scientific,
Australia). Proteins were visualised by chemilumines-
cence (Immun-Star; Bio-Rad, USA) using the Chemi-
Doc system (Bio-Rad, USA).
Immunopurified P1/P2 retinal ganglion cell cultures
P1 Wistar pups were euthanised by IP Lethabarb over-
dose and retinas dissected free in PBS. Retinas were
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Postnatal Neurons (MiltenyBiotec, Australia), and RGCs
purified using the MACS RGC Isolation Kit (MiltenyiBio-
tec, Australia) according to manufacturer’s instructions.
Purified RGCs were resuspended in growth media
(Neurobasal media (Invitrogen, Australia), 1X B27 supple-
ment (Invitrogen, Australia), 1.25 μM transferrin (Sigma-
Aldrich, Australia), 0.2 μM progesterone (Sigma-Aldrich,
Australia), 100 μM putrescine (Sigma-Aldrich, Australia),
230 nM sodium selenite (Sigma-Aldrich), 1.5 μM bovine
serum albumin (Sigma-Aldrich, Australia), 872 nM bovine
pancreas insulin (Sigma-Aldrich, Australia), 1 mM L-
glutamine (Invitrogen, Australia), 30.6 μM N-acetyl-cyst-
eine (Sigma-Aldrich, Australia), 6 nM triiodithyronine (T3;
Sigma-Aldrich, Australia), 1 mM sodium pyruvate (Sigma-
Aldrich, Australia)) fortified with growth factors (5 μM
insulin (Sigma-Aldrich, Australia), 5 μM forskolin (Sigma-
Aldrich, Australia), 440 pM rat ciliary neurotrophic factor
(CNTF; PeproTech, USA), 1.85 nM human brain-derived
neurotrophic factor (BDNF; PeproTech, USA) to increase
survival as previously described [103]. Cells were seeded
onto PDL (100 μg/mL; Sigma-Aldrich, USA) and mouse
laminin (10 μg/mL; Invitrogen, Australia) coated BD Cul-
tureSlides (BD, Australia) at approximately 6,000 cells per
mm2.Purified retinal ganglion cell growth cone collapse assay
Purified RGC cultures were grown overnight at 37°C and
5% pCO2. The following day (effectively P2) 30 μL of condi-
tioned media was added to the 300 μL of growth media in
each well and incubated at 37°C and 5% pCO2 for 30 mi-
nutes. Cultures were then fixed with 4% PFA and stained
for βIII-tubulin and F-actin. Epifluorescent photomicro-
graphs were taken of all neurons in all cultures, and
encoded such that analysis was completed blind to treat-
ment group. Growth cones were scored as either collapsed
or uncollapsed [104]: uncollapsed if the neurite itself was at
least two cell body widths in length, and the growth cone
spread with an arc of at least approximately 60°; other
growth cones on neurites at least two cell body widths in
length were classified as collapsed. The number of collapsed
and uncollapsed growth cones was normalised to totals in
the control group, and compared using a Chi-square test.
The minimum number of growth cones counted per group
was 50, and the assay was repeated to confirm results.Additional files
Additional file 1: Table S1. Pairwise statistical comparisons of expression
data. Normalised data were analysed for changes between developmental
groups by Kruskal-Wallis ANOVA (analysis of variance). When Kruskal Wallis
ANOVA resulted in p < 0.05 pairwise tests of statistical significance between
time points were performed by Mann–Whitney U tests. e: p = 0.05; * p < 0.05;
** p < 0.01.Additional file 2: Figure S1. Recombinant Sema3 protein expression in
conditioned media. A: Presented are three different blots, lined up against
the same ladder. Controls were from cultures that underwent a sham
transfection (no plasmid). Boxes indicated bands of expected molecular
weights. Detected bands for SEMA3A-GFP correspond to the approximately
130 kDa and 90 kDa bands reported previously [75]. SEMA3C-FLAG was
detected at around 80 kDa as expected, and also in a presumably
processed form at around 70 kDa. Both SEMA3C-FLAG and SEMA3E-
FLAG were detected in media at approximately 100 kDa, which might
represent glycosylated forms of the proteins. SEMA3F-AP was detected
at 150 kDa, in line with expectations. B-G: recombinant Class 3 Semaphorin
expression in HEK-293 T cells transfected with expression plasmids for
Sema3a-GFP, Sema3c-FLAG, Sema3e-FLAG, and Sema3f-AP, as well as a no
plasmid control. SEMA3A-GFP expression was visualised directly by
epifluorescence (B), SEMA3B-FLAG (C) and SEMA3E-FLAG (D) was
detected following fluorescence immunocytochemistry, and SEMA3F-
AP was detected by the presence of colour reaction product from NBT/
BCIP (F). Scale bar: 50 μM.
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